Zai Lab (ZLAB) Competitors $33.78 +2.79 (+9.00%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$33.55 -0.23 (-0.68%) As of 02/21/2025 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ZLAB vs. RDY, PCVX, SRPT, QGEN, ASND, ROIV, RVMD, LEGN, BBIO, and AXSMShould you be buying Zai Lab stock or one of its competitors? The main competitors of Zai Lab include Dr. Reddy's Laboratories (RDY), Vaxcyte (PCVX), Sarepta Therapeutics (SRPT), Qiagen (QGEN), Ascendis Pharma A/S (ASND), Roivant Sciences (ROIV), Revolution Medicines (RVMD), Legend Biotech (LEGN), BridgeBio Pharma (BBIO), and Axsome Therapeutics (AXSM). These companies are all part of the "pharmaceutical products" industry. Zai Lab vs. Dr. Reddy's Laboratories Vaxcyte Sarepta Therapeutics Qiagen Ascendis Pharma A/S Roivant Sciences Revolution Medicines Legend Biotech BridgeBio Pharma Axsome Therapeutics Zai Lab (NASDAQ:ZLAB) and Dr. Reddy's Laboratories (NYSE:RDY) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, community ranking, profitability and media sentiment. Which has higher valuation and earnings, ZLAB or RDY? Dr. Reddy's Laboratories has higher revenue and earnings than Zai Lab. Zai Lab is trading at a lower price-to-earnings ratio than Dr. Reddy's Laboratories, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZai Lab$266.72M13.86-$334.62M-$2.77-12.19Dr. Reddy's Laboratories$311.31B0.04$668M$0.6321.17 Which has more risk & volatility, ZLAB or RDY? Zai Lab has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Comparatively, Dr. Reddy's Laboratories has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500. Do institutionals & insiders hold more shares of ZLAB or RDY? 41.7% of Zai Lab shares are held by institutional investors. Comparatively, 3.8% of Dr. Reddy's Laboratories shares are held by institutional investors. 13.9% of Zai Lab shares are held by insiders. Comparatively, 2.0% of Dr. Reddy's Laboratories shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is ZLAB or RDY more profitable? Dr. Reddy's Laboratories has a net margin of 17.25% compared to Zai Lab's net margin of -76.14%. Dr. Reddy's Laboratories' return on equity of 17.87% beat Zai Lab's return on equity.Company Net Margins Return on Equity Return on Assets Zai Lab-76.14% -36.97% -27.10% Dr. Reddy's Laboratories 17.25%17.87%12.32% Does the MarketBeat Community favor ZLAB or RDY? Dr. Reddy's Laboratories received 94 more outperform votes than Zai Lab when rated by MarketBeat users. However, 64.31% of users gave Zai Lab an outperform vote while only 59.33% of users gave Dr. Reddy's Laboratories an outperform vote. CompanyUnderperformOutperformZai LabOutperform Votes22764.31% Underperform Votes12635.69% Dr. Reddy's LaboratoriesOutperform Votes32159.33% Underperform Votes22040.67% Does the media favor ZLAB or RDY? In the previous week, Zai Lab had 2 more articles in the media than Dr. Reddy's Laboratories. MarketBeat recorded 8 mentions for Zai Lab and 6 mentions for Dr. Reddy's Laboratories. Zai Lab's average media sentiment score of 0.69 beat Dr. Reddy's Laboratories' score of -0.04 indicating that Zai Lab is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zai Lab 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Dr. Reddy's Laboratories 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Do analysts rate ZLAB or RDY? Zai Lab currently has a consensus price target of $55.00, indicating a potential upside of 62.82%. Dr. Reddy's Laboratories has a consensus price target of $17.00, indicating a potential upside of 27.48%. Given Zai Lab's stronger consensus rating and higher probable upside, equities research analysts clearly believe Zai Lab is more favorable than Dr. Reddy's Laboratories.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zai Lab 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Dr. Reddy's Laboratories 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryZai Lab beats Dr. Reddy's Laboratories on 11 of the 18 factors compared between the two stocks. Get Zai Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZLAB vs. The Competition Export to ExcelMetricZai LabPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.39B$7.07B$5.81B$9.02BDividend YieldN/A2.77%4.77%3.84%P/E RatioN/A3.9221.5016.68Price / Sales13.86314.28453.1985.13Price / CashN/A67.8343.9637.32Price / Book4.206.757.654.65Net Income-$334.62M$138.11M$3.18B$245.69M7 Day Performance16.48%-2.54%-1.95%-2.67%1 Month Performance26.85%-2.00%-0.23%-2.16%1 Year Performance68.23%-5.04%16.69%12.90% Zai Lab Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZLABZai Lab2.5867 of 5 stars$33.78+9.0%$55.00+62.8%+69.7%$3.39B$266.72M0.002,175Upcoming EarningsNews CoverageGap UpHigh Trading VolumeRDYDr. Reddy's Laboratories2.8785 of 5 stars$13.60-2.8%$17.00+25.0%-11.9%$11.35B$311.31B21.6527,048Gap DownPCVXVaxcyte2.5871 of 5 stars$84.00+0.2%$127.71+52.0%+10.4%$10.47BN/A-18.26160Insider TradePositive NewsSRPTSarepta Therapeutics4.4983 of 5 stars$107.95-1.4%$176.77+63.8%-19.7%$10.31B$1.24B86.361,314Upcoming EarningsQGENQiagen4.4342 of 5 stars$39.85-0.5%$48.78+22.4%-5.2%$8.84B$1.98B110.975,967Analyst DowngradeASNDAscendis Pharma A/S3.1849 of 5 stars$144.08+1.1%$193.43+34.3%-3.0%$8.74B$288.08M-17.83640Analyst ForecastROIVRoivant Sciences2.7497 of 5 stars$10.56+1.1%$18.08+71.2%-7.5%$7.69B$122.59M1.87860Insider TradeRVMDRevolution Medicines4.5103 of 5 stars$40.67-1.6%$66.25+62.9%+41.7%$6.84B$11.58M-11.33250LEGNLegend Biotech2.594 of 5 stars$36.42+0.1%$79.50+118.3%-33.7%$6.65B$285.14M-38.341,800News CoveragePositive NewsGap UpBBIOBridgeBio Pharma4.7202 of 5 stars$34.90+10.6%$49.08+40.6%+7.9%$6.60B$9.30M-14.48400Earnings ReportAnalyst ForecastInsider TradeNews CoverageGap UpAXSMAxsome Therapeutics4.5266 of 5 stars$131.15-0.4%$147.13+12.2%+67.8%$6.36B$270.60M-20.08380Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage Related Companies and Tools Related Companies Dr. Reddy's Laboratories Alternatives Vaxcyte Alternatives Sarepta Therapeutics Alternatives Qiagen Alternatives Ascendis Pharma A/S Alternatives Roivant Sciences Alternatives Revolution Medicines Alternatives Legend Biotech Alternatives BridgeBio Pharma Alternatives Axsome Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ZLAB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zai Lab Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Zai Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
